Q1 2024 Earnings Call May 11, 2024 Crinetics Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds ...

According to the latest report by Report Ocean, titled this “Vietnam Peptide Therapeutics Market” Report gives evaluation and ...

Cory Jubinville, PhD, an analyst from LifeSci Capital, maintained the Buy rating on Crinetics Pharmaceuticals (CRNX – Research Report).

H.C. Wainwright analyst Douglas Tsao has reiterated their bullish stance on CRNX stock, giving a Buy rating today. Douglas Tsao has given his ...

Late-Breaking Presentations of Initial Results From Phase 2 Studies of Atumelnant (CRN04894) in Congenital Adrenal Hyperplasia and ACTH-Dependent Cushing's Syndrome Will be Presented at ENDO June ...

Late-Breaking Presentations of Initial Results From Phase 2 Studies of Atumelnant (CRN04894) in Congenital Adrenal ...

Designation reflects the seriousness of the disease and the potential for eneboparatide to address the urgent need for new treatment options that address key treatment goals in hypoparathyroidism LYON ...

Jeison Rodriguez Hernandez, a 28-year-old Venezuelan man with the world's largest feet, received custom-made shoes from a ...

According to a recent report by Market.us, the Global Acromegaly Treatment Market size is expected to be worth around USD 3.4 Billion by 2033 from USD 1.6 Billion in 2023, growing at a CAGR of 7.7% ...

Frontal bossing, also known as skull bossing, is a skeletal deformity that causes the frontal bones of the skull to become enlarged and protrude, resulting in an unusually pronounced forehead. There ...